Valuation DexCom, Inc. BOERSE MUENCHEN
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.40 EUR | +6.27% |
|
+14.94% | +26.62% |
| 07-31 | DexCom Shares Jump After Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised | MT |
| 07-31 | DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 31,491 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 21.65% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 31,205 | 30,199 | 29,233 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 19.06% | -3.22% | -3.2% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 33.8x | 28.3x | 23.4x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.7x | 8.24x | 6.27x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.9x | 1.5x | 1.1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 6.02x | 5.42x | 4.87x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.97x | 5.19x | 4.52x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 18.7x | 15.7x | 13.2x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 25x | 20.8x | 16.9x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 30.4x | 24.2x | 19.1x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.28% | 4.14% | 5.23% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.471 | 2.95 | 3.567 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,230 | 5,815 | 6,472 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,664 | 1,924 | 2,220 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,247 | 1,454 | 1,727 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 960.7 | 1,165 | 1,431 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -286.1 | -1,292 | -2,257 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 83.45 | 83.45 | 83.45 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 377,361 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.26x | 4.12x | 15.99x | 2.44% | 183B | |
| 19.35x | 3.38x | 11.9x | 3.48% | 109B | |
| 17.32x | 0.19x | 12.22x | 0.76% | 60.57B | |
| 30.21x | 7.51x | 18.82x | 1.35% | 51.8B | |
| 36.06x | 3.22x | 10.97x | 2.37% | 45.64B | |
| 37.66x | 1.37x | 12.1x | 0.21% | 33.22B | |
| 39.76x | 6.96x | 24.98x | 0.26% | 24B | |
| 24.32x | 3.69x | 12.93x | 1.14% | 22.26B | |
| 20.37x | 2.82x | 10.88x | 1.55% | 21.51B | |
| Average | 28.37x | 3.70x | 14.53x | 1.51% | 61.24B | |
| Weighted average by Cap. | 27.39x | 3.67x | 14.45x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
